| Guidelines for the use and interpretation of assays for monitoring autophagy | Autophagy | 2012 | 2.8K |
| Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial | JAMA - Journal of the American Medical Association | 2007 | 1.1K |
| SMAD proteins control DROSHA-mediated microRNA maturation | Nature | 2008 | 1.1K |
| Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy | New England Journal of Medicine | 2003 | 928 |
| Cardiotoxicity of the cancer therapeutic agent imatinib mesylate | Nature Medicine | 2006 | 920 |
| Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update | Physiological Reviews | 2012 | 884 |
| Acute and reversible cardiomyopathy provoked by stress in women from the United States | Circulation | 2005 | 848 |
| Outcomes of anatomical versus functional testing for coronary artery disease | New England Journal of Medicine | 2015 | 792 |
| Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy | Journal of the American College of Cardiology | 2010 | 621 |
| High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase | Nature Medicine | 2001 | 615 |
| Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction | Circulation | 2006 | 614 |
| Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community | Journal of the American College of Cardiology | 2003 | 600 |
| Acute heart failure syndromes: current state and framework for future research | Circulation | 2005 | 583 |
| Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial | Circulation | 2002 | 567 |
| Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction | Journal of the American College of Cardiology | 2001 | 558 |
| Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke | New England Journal of Medicine | 2017 | 534 |
| Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy | Journal of the American College of Cardiology | 2005 | 514 |
| Protein kinase cascades in the regulation of cardiac hypertrophy | Journal of Clinical Investigation | 2005 | 476 |
| Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice | Nature Medicine | 1997 | 397 |
| Human vascular smooth muscle cells contain functional estrogen receptor | Circulation | 1994 | 392 |
| Protective effects of estrogen on the cardiovascular system | American Journal of Cardiology | 2002 | 375 |
| Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy | Circulation | 2008 | 368 |
| Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways | Journal of Biological Chemistry | 2005 | 358 |
| Uric acid and incident kidney disease in the community | Journal of the American Society of Nephrology: JASN | 2008 | 322 |
| Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure | Nature Medicine | 2003 | 321 |
